First Department of Psychiatry, Eginition Hospital, Medical School of National and Kapodistrian, University of Athens, Athens, Greece.
University Mental Health Neurosciences and Precision Medicine Research Institute "Costas Stefanis", Athens, Greece.
Psychiatriki. 2021 Sep 20;32(3):247-250. doi: 10.22365/jpsych.2021.011. Epub 2021 Mar 26.
Infliximab (IFX) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. This is case of a 45year old female patient who had suicidal thoughts after receiving infusions with IFX. She did not report any family psychiatric history. She was diagnosed with ulcerative colitis. She had many relapses and she was treated with azathioprine and prednisolone. After many incidents of diarrhea, she started therapy with infliximab infusions. She had totally 13 infusions during a period of 13 months. The last year and in particular during the time of Infliximab intake, she reported suicidal ideation. Due to lack of improvement in her physical symptoms, she voluntarily discontinued medication and resorted to a nutritionist and a mental health counselor, where she followed cognitive and behavioral interventions. Treatment of autoimmune disorders with infliximab raise an awareness among medical and paramedical staff involved in the care of these patients about the psychiatric side effects of the drug.
英夫利昔单抗(IFX)是一种嵌合型单克隆抗体生物药物,可作用于肿瘤坏死因子-α(TNF-α),用于治疗自身免疫性疾病。本文报道了 1 例 45 岁女性患者在接受 IFX 输注后出现自杀念头的病例。该患者无家族精神病史,被诊断为溃疡性结肠炎。她反复发作,曾接受硫唑嘌呤和泼尼松龙治疗。在多次腹泻后,她开始接受英夫利昔单抗输注治疗。在 13 个月期间共接受了 13 次输注。在过去的一年中,特别是在接受英夫利昔单抗治疗期间,她报告有自杀意念。由于她的身体症状没有改善,她自愿停止了药物治疗,并向营养师和心理健康顾问寻求帮助,在那里她接受了认知和行为干预。英夫利昔单抗治疗自身免疫性疾病引起了参与这些患者护理的医疗和辅助医疗人员对该药物精神副作用的关注。